Innoventric Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $28.5M

  • Investors
  • 8

Innoventric General Information

Description

Developer of percutaneous devices designed to provide treatment of tricuspid regurgitation. The company's device offers functional tricuspid valve replacement that utilizes Cross-Caval anchoring and a unique multi-valve design, for long-lasting blood flow regulation, enabling patients to improve their lifespan and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Chaim Holzman Street
  • Rehovot
  • Israel
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Corporate Office
  • 1 Chaim Holzman Street
  • Rehovot
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innoventric Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 29-Oct-2024 $28.5M Completed Generating Revenue
4. Later Stage VC (Series A) 01-Nov-2021 Completed Clinical Trials - General
3. Grant 16-Jun-2021 Completed Generating Revenue
2. Seed Round 14-Apr-2019 $3.5M $4.25M Completed Clinical Trials - General
1. Seed Round 01-Jan-2017 $745K $745K Completed Clinical Trials - General
To view Innoventric’s complete valuation and funding history, request access »

Innoventric Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred B-1
Series A
Preferred Seed 2 2,060,936 $0.010000 $1.7 $1.7 1x $1.7 20.52%
Preferred Seed1 512,654 $0.010000 $1.45 $1.45 1x $1.45 5.1%
To view Innoventric’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Innoventric Patents

Innoventric Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026115550-A1 Systems, methods and devices for treating tricuspid insufficiency Pending 27-Nov-2024
WO-2026013677-A1 Medical implant storage apparatus Pending 11-Jul-2024
AU-2023369556-A1 Systems, methods, and devices for treating a diseased or otherwise damaged tricuspid valve Pending 24-Oct-2022
EP-4608332-A1 Systems, methods, and devices for treating a diseased or otherwise damaged tricuspid valve Pending 24-Oct-2022
EP-4608332-A4 Systems, methods, and devices for treating a diseased or otherwise damaged tricuspid valve Pending 24-Oct-2022 A61F2/2418
To view Innoventric’s complete patent history, request access »

Innoventric Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innoventric Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mivtach Shamir Holdings PE/Buyout Minority
RA Capital Management Asset Manager Minority
European Commission Government Minority
JG Investment PE/Buyout Minority
European Innovation Council Accelerator/Incubator Minority
You’re viewing 5 of 8 investors. Get the full list »

Innoventric FAQs

  • When was Innoventric founded?

    Innoventric was founded in 2016.

  • Where is Innoventric headquartered?

    Innoventric is headquartered in Rehovot, Israel.

  • What is the size of Innoventric?

    Innoventric has 22 total employees.

  • What industry is Innoventric in?

    Innoventric’s primary industry is Therapeutic Devices.

  • Is Innoventric a private or public company?

    Innoventric is a Private company.

  • What is the current valuation of Innoventric?

    The current valuation of Innoventric is .

  • What is Innoventric’s current revenue?

    The current revenue for Innoventric is .

  • How much funding has Innoventric raised over time?

    Innoventric has raised $44.2M.

  • Who are Innoventric’s investors?

    Mivtach Shamir Holdings, RA Capital Management, European Commission, JG Investment, and European Innovation Council are 5 of 8 investors who have invested in Innoventric.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process